These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 26258765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New Strategies to Treat High Cholesterol.
    Blum CB, Stone NJ.
    JAMA; 2016 Mar 15; 315(11):1169. PubMed ID: 26978218
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target].
    Guijarro C, Ruilope LM.
    Med Clin (Barc); 2015 Jul 20; 145(2):67-9. PubMed ID: 26004275
    [No Abstract] [Full Text] [Related]

  • 7. [Effective LDL cholesterol reduction for high risk patients].
    Einecke D.
    MMW Fortschr Med; 2016 Apr 28; 158(8):84. PubMed ID: 27116175
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antihyperlipidemic therapies targeting PCSK9.
    Weinreich M, Frishman WH.
    Cardiol Rev; 2014 Apr 28; 22(3):140-6. PubMed ID: 24407047
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dyslipidaemia in 2015: Advances in treatment of dyslipidaemia.
    Grundy SM.
    Nat Rev Cardiol; 2016 Feb 28; 13(2):74-5. PubMed ID: 26763537
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predicting the Overuse of PCSK-9 Inhibitors.
    Rodriguez-Gutierrez R, Shah ND, Montori VM.
    JAMA; 2015 Nov 10; 314(18):1909-10. PubMed ID: 26547456
    [No Abstract] [Full Text] [Related]

  • 16. Highlights of the 83rd European Atherosclerosis Society (EAS) annual Congress, Glasgow 22-25 March, 2015.
    Stock J.
    Atherosclerosis; 2015 Sep 10; 242(1):45-7. PubMed ID: 26177273
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of PCSK9: is this the way forward for managing residual risk?
    Chowdhury SR, Rees A.
    Curr Opin Lipidol; 2012 Oct 10; 23(5):509-10. PubMed ID: 22964999
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.